Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18182665

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 Jan 10
First author
Berthold DR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 May 10;26(14):2413-4; author reply 2414-5. doi: 10.1200/JCO.2008.16.6124.
    note
    Source null
    related pmid
    18467737
    relationship
    Comment in
  2. citation
    Nat Clin Pract Oncol. 2008 Sep;5(9):506-7. doi: 10.1038/ncponc1201.
    note
    Source null
    related pmid
    18648352
    relationship
    Comment in
  3. citation
    Nat Clin Pract Urol. 2008 Dec;5(12):650-1. doi: 10.1038/ncpuro1232.
    note
    Source null
    related pmid
    18936787
    relationship
    Comment in

Authors and identifiers

  1. name
    Berthold DR
    type
    Author
  2. name
    Pond GR
    type
    Author
  3. name
    Soban F
    type
    Author
  4. name
    de Wit R
    type
    Author
  5. name
    Eisenberger M
    type
    Author
  6. name
    Tannock IF
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Berthold DR
    type
    Author
  2. name
    Pond GR
    type
    Author
  3. name
    Soban F
    type
    Author
  4. name
    de Wit R
    type
    Author
  5. name
    Eisenberger M
    type
    Author
  6. name
    Tannock IF
    type
    Author
bibliography ids
  1. nci-bib-594230f832af918eb764cb52
book metadata
content sha256
04d34409eca608ef2599c3b45c29978527c8da8e2c82af9a031e648627a95b66
document type
citation
dois
  1. 10.1200/JCO.2007.12.4008
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:18182665
immutable id
pubmed:18182665@04d34409eca608ef2599c3b45c29978527c8da8e2c82af9a031e648627a95b66
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
2
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
242-5
volume
26
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 May 10;26(14):2413-4; author reply 2414-5. doi: 10.1200/JCO.2008.16.6124.
    note
    Source null
    related pmid
    18467737
    relationship
    Comment in
  2. citation
    Nat Clin Pract Oncol. 2008 Sep;5(9):506-7. doi: 10.1038/ncponc1201.
    note
    Source null
    related pmid
    18648352
    relationship
    Comment in
  3. citation
    Nat Clin Pract Urol. 2008 Dec;5(12):650-1. doi: 10.1038/ncpuro1232.
    note
    Source null
    related pmid
    18936787
    relationship
    Comment in
outcomes validated
false
pmid
18182665
provenance
batch id
89a0f2206e11ca092d02
provider
NCBI PubMed ESummary
record sha256
1f7c02b5369465e50edaac8e88b689c994c4dbd9c2279d9aa776bd5161a5f4ed
response sha256
7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
retrieved at
2026-09-09T23:46:16.784581+00:00
publication date
display
2008 Jan 10
precision
day
year
2008
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18182665/
title
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.

Preserved source evidence · Not medical advice